Arkis BioSciences®

Arkis BioSciences® develops technology to innovate the neurosurgical treatments for intracranial hypertension.

[Arkis BioSciences® @ArkisBioSci]

The Arkis BioSciences team was elated by positive clinical feedback and growing enthusiasm for CerebroFlo and our less invasive surgical instrumentation at this years’ American Association of Neurological Surgeons conference in San Diego. A big thank you to all our supporters!

[Arkis BioSciences® @ArkisBioSci]

The Arkis BioSciences sales team is currently exhibiting the CerebroFlo® EVD Catheter at the 2019 Southern Neurosurgical Society conference in Key Largo, FL. (https://t.co/W68xW1b3yY)

[Arkis BioSciences® @ArkisBioSci]

https://t.co/S694DySBOR
Arkis BioSciences announces it has received ISO 13485:2016 certification for its medical device quality management system by TÜV USA, Inc. (Member of TÜV NORD Group).

[Arkis BioSciences® @ArkisBioSci]

The Arkis BioSciences team just returned from the 2018 Congress of Neurological Surgeons, where we exhibited the CerebroFlo® EVD Catheter with Endexo® Technology and our advanced surgical instrumentation, including the Single Pass Tunneling Guidewire®.

[Arkis BioSciences® @ArkisBioSci]

The Arkis BioSciences team recently exhibited the CerebroFlo™ EVD Catheter with Endexo® Technology at the NeuroTrauma 2018 conference in Toronto, highlighting the permanent surface passivation characteristics of the Endexo molecule and its importance in neurotrauma applications.

[Arkis BioSciences® @ArkisBioSci]

Arkis BioSciences® exhibited at the 2018 American Association of Neurological Surgeons, announcing a successful clinical introduction of Endexo® Technology to neurosurgical use with the new and exclusive CerebroFlo™ EVD Catheter.

[Arkis BioSciences® @ArkisBioSci]

Arkis BioSciences' new CerebroFlo™ EVD catheter garners promising clinical feedback with its introduction across the U.S. Healthcare market. Read more in the following press release: https://t.co/NfPihydjvm

[Arkis BioSciences® @ArkisBioSci]

@ArkisBioSci our CEO Chad Seaver was recently interviewed by Med Device Online’s editor Bob Marshall, who examines the methodology of product development at Arkis BioSciences, and how Arkis is addressing unmet clinical needs. https://t.co/uYCYH1Z6Np

[Arkis BioSciences® @ArkisBioSci]

@ArkisBioSci we are working to make surgical treatment of hydrocephalus more durable and less invasive. Please see our Single Pass Tunneling Guidewire™ video for more information! https://t.co/ctYJ2ypFwt

[Arkis BioSciences® @ArkisBioSci]

@ArkisBioSci we are committed to the development of new technologies to innovate surgical treatments of intracranial hypertension. Please visit our website at https://t.co/bioG0Xthie to learn more!

[Arkis BioSciences® @ArkisBioSci]

Hello Twitter! #myfirstTweet from @ArkisBioSci is an introduction of our new #CerebroFlo EVD Catheter with Endexo® Technology - the only EVD catheter with a passivated surface to limit formation of clots. https://t.co/f9pRgTWbAO